rolipram has been researched along with Amnionitis in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Chorioamnionitis is implicated in the pathophysiology of bronchopulmonary disease, and the associated inflammatory response is responsible for adverse effects on alveolar development." | 1.38 | Antenatal phosphodiesterase 4 inhibition restores postnatal growth and pulmonary development in a model of chorioamnionitis in rabbits. ( Branger, B; Caillon, J; Gras-Leguen, C; Homer, L; Jacqueline, C; Jarreau, PH; Joram, N; Launay, E; Méhats, C; Moyon, T; Potel, G; Roze, JC, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Homer, L | 1 |
Launay, E | 1 |
Joram, N | 1 |
Jacqueline, C | 1 |
Jarreau, PH | 1 |
Caillon, J | 1 |
Moyon, T | 1 |
Branger, B | 1 |
Potel, G | 1 |
Roze, JC | 1 |
Méhats, C | 1 |
Gras-Leguen, C | 1 |
1 other study available for rolipram and Amnionitis
Article | Year |
---|---|
Antenatal phosphodiesterase 4 inhibition restores postnatal growth and pulmonary development in a model of chorioamnionitis in rabbits.
Topics: Animals; Chorioamnionitis; Disease Models, Animal; Elastic Tissue; Female; Lung; Lung Volume Measure | 2012 |